Injective has facilitated $4.15 billion in tokenized equities trading, according to platform data. The broader onchain stock market — blockchain-based representations of traditional company shares — has now swelled past $1.6 billion.
What tokenized equities are
Tokenized equities let investors trade shares of real-world companies on decentralized networks. Unlike conventional stock exchanges, these markets operate around the clock, with trades recorded directly on a blockchain. Injective is one of several platforms enabling this, though its recent volume suggests it has captured a meaningful slice of the growing ecosystem.
The scale of the activity
The $4.15 billion figure covers the total value of equities trading that has passed through Injective's network. That amount alone outstrips the entire onchain stock market as recently as a few months ago. The market's climb past $1.6 billion underscores a broader shift: more traders and institutions are experimenting with blockchain-based finance for assets once confined to traditional exchanges.
Tokenized stocks aim to lower barriers — no need for a brokerage account, no settlement delays, and the ability to trade fractions of expensive shares. But the model also raises questions about custody, regulatory oversight, and how these tokens track real-world corporate actions like dividends and splits. So far, platforms like Injective have relied on third-party custodians and oracles to keep token prices aligned with off-chain markets.
The numbers signal growing confidence in the infrastructure. Whether that trust holds will depend on how regulators treat these instruments and whether the technology can handle a sustained surge in volume without hiccups.
The coming months will test whether the onchain stock market can keep its momentum as scrutiny from financial authorities intensifies.
